Figure 2 from Discovery and Validation of Molecular Biomarkers for Differentiation of Nondysplastic Barrett’s Esophagus from High-grade Dysplasia and Esophageal Adenocarcinoma

Read full text
Authors: Caroline L. Matchett, Seth W. Slettedahl, William R. Taylor, Calise K. Berger, Caryn E. Anderson, Melissa A. Passe, Ramona L. Lansing, Panwen Wang, Collin E. Chalmers, Patrick H. Foote, Jeanette E. Eckel‐Passow, Zhifu Sun
+11 more Douglas W. Mahoney, Don Chamil Codipilly, Cadman L. Leggett, Francisco C. Ramirez, Allon Kahn, Herbert C. Wolfsen, Swathi Eluri, Vani J. A. Konda, Arvind Julius Trindade, Prasad G. Iyer, John B. Kisiel
Cited by: 0

Abstract

Multistage study design from marker discovery to validation. Workflow overview of initial marker discovery using WGMS on DNA extracted from endoscopic brushing samples with cross-reference to an archival RRBS dataset from DNA extracted from independent tissue samples, and independent validation comparing paired endoscopic brushings and sponge-on-string samples. EAC, esophageal adenocarcinoma; EM-seq, enzymatic methyl sequencing; methyl-seq, methyl sequencing; WGBS, whole genome bisulfite sequencing.

Fields of Study & Subjects

Esophageal Cancer Research and Treatment Esophageal and GI Pathology Eosinophilic Esophagitis

Publication details

Publication date
6 January 2026